Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Cancer and Leukemia Group B National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00698815 |
RATIONALE: Drugs used in chemotherapy, such as pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving pemetrexed together with sunitinib may kill more tumor cells. It is not yet known whether pemetrexed and sunitinib are more effective when given alone or together in treating non-small cell lung cancer.
PURPOSE: This randomized phase II trial is studying pemetrexed and sunitinib to compare how well they work when given alone or together as second-line therapy in treating patients with stage IIIB or stage IV non-small cell lung cancer.
Condition | Intervention | Phase |
---|---|---|
Lung Cancer |
Drug: pemetrexed disodium Drug: sunitinib malate |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized |
Official Title: | A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib (NSC # 736511, IND # 74019) or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non-Small Cell Lung Cancer |
Estimated Enrollment: | 225 |
Study Start Date: | April 2008 |
Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Arm I: Active Comparator
Patients receive pemetrexed disodium IV over 10 minutes on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients with documented disease progression may then receive sunitinib malate as in arm II as third-line therapy.
|
Drug: pemetrexed disodium
Given IV
|
Arm II: Experimental
Patients receive oral sunitinib malate once daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients with documented disease progression may then receive pemetrexed disodium as in arm I as third-line therapy.
|
Drug: sunitinib malate
Given orally
|
Arm III: Experimental
Patients receive pemetrexed disodium IV over 10 minutes on day 1 and oral sunitinib malate once daily on days 1-21. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients with documented disease progression may then receive third-line therapy at the discretion of the treating physician.
|
Drug: pemetrexed disodium
Given IV
Drug: sunitinib malate
Given orally
|
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study. Patients are stratified according to ECOG performance status (0 vs 1), disease stage (IIIB vs IV), and gender.
Patients are randomized to 1 of 3 treatment arms.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed non-small cell lung cancer (NSCLC)
Measurable or non-measurable disease
Non-measurable disease is defined as all other lesions, including small lesions (i.e., longest diameter < 20 mm by conventional techniques or < 10 mm by spiral CT scan) and truly non-measurable lesions, including any of the following:
No symptomatic or untreated CNS metastases
PATIENT CHARACTERISTICS:
No symptomatic congestive heart failure within the past 12 months
Patients with a history of NYHA class II heart failure are eligible provided at least 1 of the following criteria is met:
No history of pulmonary hemorrhage, bleeding diathesis, or evidence of hemoptysis
PRIOR CONCURRENT THERAPY:
At least 28 days since prior first-line therapy
More than 7 days since prior and no concurrent CYP3A4 inhibitors, including any of the following:
More than 12 days since prior and no concurrent CYP3A4 inducers, including any of the following:
No concurrent therapeutic anticoagulation for thromboembolic disease
United States, California | |
Alta Bates Summit Medical Center - Summit Campus | Recruiting |
Oakland, California, United States, 94609 | |
Contact: Clinical Trials Office - Alta Bates Summit Medical Center - Su 510-204-1414 | |
Bay Area Breast Surgeons, Incorporated | Recruiting |
Oakland, California, United States, 94609 | |
Contact: James H. Feusner, MD 510-428-3689 | |
CCOP - Bay Area Tumor Institute | Recruiting |
Oakland, California, United States, 94609 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Contra Costa Regional Medical Center | Recruiting |
Martinez, California, United States, 94553-3156 | |
Contact: James H. Feusner, MD 510-428-3689 | |
El Camino Hospital Cancer Center | Recruiting |
Mountain View, California, United States, 94040 | |
Contact: Clinical Trials Office - El Camino Hospital Cancer Center 650-988-7623 | |
East Bay Radiation Oncology Center | Recruiting |
Castro Valley, California, United States, 94546 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Eden Medical Center | Recruiting |
Castro Valley, California, United States, 94546 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Doctors Medical Center - San Pablo Campus | Recruiting |
San Pablo, California, United States, 94806 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Highland General Hospital | Recruiting |
Oakland, California, United States, 94602 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Kaiser Permanente Medical Office -Vandever Medical Office | Recruiting |
San Diego, California, United States, 92120 | |
Contact: Han A. Koh 619-528-2596 | |
Larry G Strieff MD Medical Corporation | Recruiting |
Oakland, California, United States, 94609 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Tom K Lee, Incorporated | Recruiting |
Oakland, California, United States, 94609 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Valley Care Medical Center | Recruiting |
Pleasanton, California, United States, 94588 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Valley Medical Oncology Consultants - Castro Valley | Recruiting |
Castro Valley, California, United States, 94546 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Valley Medical Oncology Consultants - Pleasanton | Recruiting |
Pleasanton, California, United States, 94588 | |
Contact: James H. Feusner, MD 510-428-3689 | |
Valley Medical Oncology | Recruiting |
Fremont, California, United States, 94538 | |
Contact: James H. Feusner, MD 510-428-3689 | |
United States, Connecticut | |
Helen and Harry Gray Cancer Center at Hartford Hospital | Recruiting |
Hartford, Connecticut, United States, 06102-5037 | |
Contact: Clinical Trials Office - Helen and Harry Gray Cancer Center 860-545-5363 | |
United States, Delaware | |
CCOP - Christiana Care Health Services | Recruiting |
Newark, Delaware, United States, 19713 | |
Contact: Clinical Trial Office - CCOP - Christiana Care Health Services 302-733-6227 | |
Tunnell Cancer Center at Beebe Medical Center | Recruiting |
Lewes, Delaware, United States, 19958 | |
Contact: Clinical Trials Office - Tunnell Cancer Center 302-645-3171 | |
United States, Florida | |
CCOP - Mount Sinai Medical Center | Recruiting |
Miami Beach, Florida, United States, 33140 | |
Contact: Rogerio C. Lilenbaum, MD 305-535-3310 | |
Ella Milbank Foshay Cancer Center at Jupiter Medical Center | Recruiting |
Jupiter, Florida, United States, 33458 | |
Contact: Clinical Trials Office - Ella Milbank Foshay Cancer Center 561-745-5768 | |
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Clinical Trials Office - Michael and Dianne Bienes Comprehensi 954-776-3239 | |
United States, Illinois | |
Joliet Oncology-Hematology Associates, Limited - West | Recruiting |
Joliet, Illinois, United States, 60435 | |
Contact: Sanjiv S. Modi 815-730-3098 | |
University of Chicago Cancer Research Center | Recruiting |
Chicago, Illinois, United States, 60637-1470 | |
Contact: Clinical Trials Office - University of Chicago Cancer Research 773-834-7424 | |
University of Illinois Cancer Center | Recruiting |
Chicago, Illinois, United States, 60612-7243 | |
Contact: Clinical Trial Office - University of Illinois Cancer Center 312-355-3046 | |
United States, Iowa | |
Hematology Oncology Associates of the Quad Cities | Recruiting |
Bettendorf, Iowa, United States, 52722 | |
Contact: Shobha R. Chitneni, MD, MBBS 563-355-7733 | |
United States, Maine | |
CancerCare of Maine at Eastern Maine Medical Center | Recruiting |
Bangor, Maine, United States, 04401 | |
Contact: Clinical Trials Office - CancerCare of Maine 207-973-4274 | |
United States, Maryland | |
Union Hospital Cancer Program at Union Hospital | Recruiting |
Elkton MD, Maryland, United States, 21921 | |
Contact: Stephen S. Grubbs, MD 302-366-1200 | |
United States, Massachusetts | |
Dana-Farber/Brigham and Women's Cancer Center | Recruiting |
Boston, Massachusetts, United States, 02115 | |
Contact: Clinical Trials Office 617-724-5200 | |
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute | Recruiting |
Boston, Massachusetts, United States, 02115 | |
Contact: Contact Person 617-632-3474 | |
Massachusetts General Hospital | Recruiting |
Boston, Massachusetts, United States, 02114 | |
Contact: Clinical Trials Office - Massachusetts General Hospital 877-726-5130 | |
United States, Minnesota | |
Masonic Cancer Center at University of Minnesota | Recruiting |
Minneapolis, Minnesota, United States, 55455 | |
Contact: Clinical Trials Office - Masonic Cancer Center at University o 612-624-2620 | |
United States, Missouri | |
Arch Medical Services, Incorporated at Center for Cancer Care and Research | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Alan P. Lyss, MD 314-996-5514 | |
Ellis Fischel Cancer Center at University of Missouri - Columbia | Recruiting |
Columbia, Missouri, United States, 65203 | |
Contact: Clinical Trial Office - Ellis Fischel Cancer Center 573-882-4894 | |
Missouri Baptist Cancer Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Alan P. Lyss, MD 314-996-5514 | |
United States, Nebraska | |
Alegant Health Cancer Center at Bergan Mercy Medical Center | Recruiting |
Omaha, Nebraska, United States, 68124 | |
Contact: Clinical Trials Office - Alegant Health Cancer Center at Berge 402-398-6060 | |
Callahan Cancer Center at Great Plains Regional Medical Center | Recruiting |
North Platte, Nebraska, United States, 69103 | |
Contact: Clinical Trials Office - Callahan Cancer Center at Great Plain 308-696-7864 | |
Cancer Resource Center - Lincoln | Recruiting |
Lincoln, Nebraska, United States, 68510 | |
Contact: Alan R. Berg, MD 402-420-7000 | |
CCOP - Missouri Valley Cancer Consortium | Recruiting |
Omaha, Nebraska, United States, 68106 | |
Contact: Gamini S. Soori, MD, FACP, FRCP, MBA 402-393-3110 | |
Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Apar K. Ganti 308-398-5450 | |
Immanuel Medical Center | Recruiting |
Omaha, Nebraska, United States, 68122 | |
Contact: Gamini S. Soori, MD, FACP, FRCP, MBA 402-393-3110 | |
Methodist Estabrook Cancer Center | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Robert M. Langdon, MD 402-399-8762 | |
Creighton University Medical Center | Recruiting |
Omaha, Nebraska, United States, 68131-2197 | |
Contact: Clinical Trials Office - Creighton University Medical Center 402-280-4100 | |
UNMC Eppley Cancer Center at the University of Nebraska Medical Center | Recruiting |
Omaha, Nebraska, United States, 68198-6805 | |
Contact: Clinical Trials Office - UNMC Eppley Cancer Center at the Univ 800-999-5465 | |
United States, New Jersey | |
Cancer Institute of New Jersey at Cooper - Voorhees | Recruiting |
Voorhees, New Jersey, United States, 08043 | |
Contact: Clinical Trials Office - Cancer Institute of New Jersey at Coo 856-325-6757 | |
United States, New York | |
CCOP - North Shore University Hospital | Recruiting |
Manhasset, New York, United States, 11030 | |
Contact: Haralambos Raftopoulos, MD 212-305-0591 | |
Charles R. Wood Cancer Center at Glens Falls Hospital | Recruiting |
Glens Falls, New York, United States, 12801 | |
Contact: Clinical Trials Office - Charles R. Wood Cancer Center at Glen 518-926-6700 | |
SUNY Upstate Medical University Hospital | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Clinical Trials Office - SUNY Upstate Medical University Hospi 315-464-5476 | |
Long Island Jewish Medical Center | Recruiting |
New Hyde Park, New York, United States, 11040 | |
Contact: Haralambos Raftopoulos, MD 212-305-0591 | |
Monter Cancer Center of the North Shore-LIJ Health System | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Haralambos Raftopoulos, MD 212-305-0591 | |
Don Monti Comprehensive Cancer Center at North Shore University Hospital | Recruiting |
Manhasset, New York, United States, 11030 | |
Contact: Clinical Trials Office - Don Monti Comprehensive Cancer Center 516-734-8900 | |
Veterans Affairs Medical Center - Syracuse | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Ajeet Gajra, MD 315-425-4666 | |
United States, North Carolina | |
Annie Penn Cancer Center | Recruiting |
Reidsville, North Carolina, United States, 27320 | |
Contact: Clinical Trials Office - Annie Penn Cancer Center 336-621-8374 | |
Kinston Medical Specialists | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Peter R. Watson, MD 252-559-2200ext.201 | |
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill | Recruiting |
Chapel Hill, North Carolina, United States, 27599-7295 | |
Contact: Clinical Trials Office - Lineberger Comprehensive Cancer Cente 877-668-0683; 919-966-4432 | |
Moses Cone Regional Cancer Center at Wesley Long Community Hospital | Recruiting |
Greensboro, North Carolina, United States, 27403-1198 | |
Contact: Clinical Trials Office - Moses Cone Regional Cancer Center at 336-621-8374 | |
Wayne Memorial Hospital, Incorporated | Recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Contact: James N. Atkins, MD 919-580-0000 | |
Randolph Hospital | Recruiting |
Asheboro, North Carolina, United States, 27203-5400 | |
Contact: Clinical Trails Office - Randolph Hospital 336-832-0821 | |
Wake Forest University Comprehensive Cancer Center | Recruiting |
Winston-Salem, North Carolina, United States, 27157-1096 | |
Contact: Clinical Trials Office - Wake Forest University Comprehensive 336-713-6771 | |
Presbyterian Cancer Center at Presbyterian Hospital | Recruiting |
Charlotte, North Carolina, United States, 28233-3549 | |
Contact: Clinical Trials Office - Presbyterian Cancer Center at Presbyt 704-384-5369 | |
United States, Ohio | |
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center | Recruiting |
Columbus, Ohio, United States, 43210-1240 | |
Contact: Ohio State University Cancer Clinical Trial Matching Service 866-627-7616 osu@emergingmed.com | |
United States, Rhode Island | |
Memorial Hospital of Rhode Island | Recruiting |
Pawtucket, Rhode Island, United States, 02860 | |
Contact: Humera Khurshid 401-729-2000 | |
United States, South Carolina | |
CCOP - Greenville | Recruiting |
Greenville, South Carolina, United States, 29615 | |
Contact: Jeffrey K. Giguere, MD, FACP 864-987-7000 | |
McLeod Regional Medical Center | Recruiting |
Florence, South Carolina, United States, 29501 | |
Contact: Clinical Trials Office - McLeod Regional Medical Center 843-679-7256 | |
United States, Vermont | |
Fletcher Allen Health Care - University Health Center Campus | Recruiting |
Burlington, Vermont, United States, 05401 | |
Contact: Clinical Trials Office - Fletcher Allen Health Care 802-656-8990 | |
Mountainview Medical | Recruiting |
Berlin, Vermont, United States, 05602 | |
Contact: Steven M. Grunberg, MD 802-847-3827 | |
United States, Virginia | |
Ravenel Oncology Center at Memorial Hospital of Martinsville and Henry County | Recruiting |
Martinsville, Virginia, United States, 24115 | |
Contact: Arthur Sleeper, MD 276-666-7200 | |
United States, West Virginia | |
St. Mary's Regional Cancer Center at St. Mary's Medical Center | Recruiting |
Huntington, West Virginia, United States, 25702 | |
Contact: Gerrit A. Kimmey, MD 304-528-4645 |
Study Chair: | Mark A. Socinski, MD | UNC Lineberger Comprehensive Cancer Center |
Investigator: | Rebecca S. Heist, MD | Harvard School of Public Health |
Responsible Party: | Cancer and Leukemia Group B ( Richard L. Schilsky ) |
Study ID Numbers: | CDR0000589102, CALGB-30704 |
Study First Received: | June 14, 2008 |
Last Updated: | May 7, 2009 |
ClinicalTrials.gov Identifier: | NCT00698815 History of Changes |
Health Authority: | Unspecified |
stage IIIB non-small cell lung cancer stage IV non-small cell lung cancer recurrent non-small cell lung cancer |
Antimetabolites Thoracic Neoplasms Folate Folinic Acid Folic Acid Antagonists Angiogenesis Inhibitors Vitamin B9 Recurrence Carcinoma |
Pemetrexed Folic Acid Respiratory Tract Diseases Lung Neoplasms Sunitinib Lung Diseases Non-small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |
Thoracic Neoplasms Antimetabolites Antimetabolites, Antineoplastic Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Physiological Effects of Drugs Neoplasms by Site Respiratory Tract Diseases Sunitinib Lung Neoplasms Therapeutic Uses Growth Inhibitors Angiogenesis Modulating Agents |
Respiratory Tract Neoplasms Neoplasms by Histologic Type Growth Substances Enzyme Inhibitors Folic Acid Antagonists Angiogenesis Inhibitors Pharmacologic Actions Carcinoma Pemetrexed Neoplasms Lung Diseases Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |